Literature DB >> 11252643

A theoretical reappraisal of mixed states: dysphoria as a third dimension.

A Dayer1, J M Aubry, L Roth, S Ducrey, G Bertschy.   

Abstract

Mixed states are heterogeneous clinical entities difficult to define precisely. The stringent actual DSM IV criteria are unsatisfactory for current clinical use. Many frequently encountered mixed patients benefit without an accurate diagnosis from biological therapeutic interventions such as the introduction of mood stabilizers. We propose a brief review of the definition and characteristics of mixed states and propose a new approach to the typology of mixed states. Based on recent literature data, we add to the depressive and manic syndrome the concept of dysphoria as a third dimension. Integrating this three dimensional approach with recent factor analysis, we describe in addition to the DSM IV mixed state (type I) two new subtypes of mixed states (type IIM and IID). This new typology can give the clinician a more accurate understanding of the complex and polymorphous reality of mixed states and help him make more specific therapeutic interventions. These subtypes of mixed states will need validation through prospective clinical studies. Biological differences, differential outcome over time, and differential response to treatment will be important validation criteria.

Entities:  

Mesh:

Year:  2000        PMID: 11252643     DOI: 10.1034/j.1399-5618.2000.020404.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  2 in total

1.  Specificity of the Relationships Between Dysphoria and Related Constructs in an Outpatient Sample.

Authors:  Vladan Starcevic; David Berle; Kirupamani Viswasam; Anthony Hannan; Denise Milicevic; Vlasios Brakoulias; Erin Dale
Journal:  Psychiatr Q       Date:  2015-12

2.  Combining an SSRI with an anticonvulsant in depressed patients with dysphoric mood: an open study.

Authors:  Massimo Pasquini; Angelo Picardi; Azzurra Speca; Valerio Orlandi; Lorenzo Tarsitani; Pierluigi Morosini; Isabella Cascavilla; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.